Allarity Therapeutics Statistics
Total Valuation
ALLR has a market cap or net worth of $20.87 million. The enterprise value is $22.56 million.
Important Dates
The last earnings date was Friday, May 15, 2026, after market close.
| Earnings Date | May 15, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ALLR has 15.46 million shares outstanding. The number of shares has increased by 254.81% in one year.
| Current Share Class | 15.46M |
| Shares Outstanding | 15.46M |
| Shares Change (YoY) | +254.81% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | 0.47% |
| Owned by Institutions (%) | 6.15% |
| Float | 15.39M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 60.50 |
| Forward PS | n/a |
| PB Ratio | 3.09 |
| P/TBV Ratio | 3.02 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 65.38 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.23, with a Debt / Equity ratio of 3.11.
| Current Ratio | 1.23 |
| Quick Ratio | 0.75 |
| Debt / Equity | 3.11 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -34.33 |
Financial Efficiency
Return on equity (ROE) is -87.92% and return on invested capital (ROIC) is -31.62%.
| Return on Equity (ROE) | -87.92% |
| Return on Assets (ROA) | -23.70% |
| Return on Invested Capital (ROIC) | -31.62% |
| Return on Capital Employed (ROCE) | -177.12% |
| Weighted Average Cost of Capital (WACC) | 3.79% |
| Revenue Per Employee | $43,125 |
| Profits Per Employee | -$1.41M |
| Employee Count | 8 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +39.18% in the last 52 weeks. The beta is 0.38, so ALLR's price volatility has been lower than the market average.
| Beta (5Y) | 0.38 |
| 52-Week Price Change | +39.18% |
| 50-Day Moving Average | 1.28 |
| 200-Day Moving Average | 1.24 |
| Relative Strength Index (RSI) | 48.25 |
| Average Volume (20 Days) | 225,469 |
Short Selling Information
The latest short interest is 274,063, so 1.77% of the outstanding shares have been sold short.
| Short Interest | 274,063 |
| Short Previous Month | 298,381 |
| Short % of Shares Out | 1.77% |
| Short % of Float | 1.78% |
| Short Ratio (days to cover) | 2.16 |
Income Statement
In the last 12 months, ALLR had revenue of $345,000 and -$11.25 million in losses. Loss per share was -$0.72.
| Revenue | 345,000 |
| Gross Profit | 345,000 |
| Operating Income | -12.26M |
| Pretax Income | -11.25M |
| Net Income | -11.25M |
| EBITDA | n/a |
| EBIT | -12.26M |
| Loss Per Share | -$0.72 |
Full Income StatementBalance Sheet
The company has $19.81 million in cash and $21.50 million in debt, with a net cash position of -$1.68 million or -$0.11 per share.
| Cash & Cash Equivalents | 19.81M |
| Total Debt | 21.50M |
| Net Cash | -1.68M |
| Net Cash Per Share | -$0.11 |
| Equity (Book Value) | 6.92M |
| Book Value Per Share | 0.44 |
| Working Capital | 6.50M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$16.63 million and capital expenditures -$72,000, giving a free cash flow of -$16.70 million.
| Operating Cash Flow | -16.63M |
| Capital Expenditures | -72,000 |
| Depreciation & Amortization | -50,000 |
| Net Borrowing | 20.00M |
| Free Cash Flow | -16.70M |
| FCF Per Share | -$1.08 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -3,552.75% |
| Pretax Margin | -3,260.58% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ALLR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -254.81% |
| Shareholder Yield | -254.81% |
| Earnings Yield | -53.90% |
| FCF Yield | -80.01% |
Analyst Forecast
The average price target for ALLR is $9.75, which is 622.22% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $9.75 |
| Price Target Difference | 622.22% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 11, 2024. It was a reverse split with a ratio of 1:30.
| Last Split Date | Sep 11, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:30 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |
